Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 1;8(6):4306-4311.
doi: 10.1039/c6sc05435h. Epub 2017 Apr 7.

Coupling functionalized cobalt ferrite nanoparticle enrichment with online LC/MS/MS for top-down phosphoproteomics

Affiliations

Coupling functionalized cobalt ferrite nanoparticle enrichment with online LC/MS/MS for top-down phosphoproteomics

Bifan Chen et al. Chem Sci. .

Abstract

Phosphorylation plays pivotal roles in cellular processes and dysregulated phosphorylation is considered as an underlying mechanism in many human diseases. Top-down mass spectrometry (MS) analyzes intact proteins and provides a comprehensive analysis of protein phosphorylation. However, top-down MS-based phosphoproteomics is challenging due to the difficulty in enriching low abundance intact phosphoproteins as well as separating and detecting the enriched phosphoproteins from complex mixtures. Herein, we have designed and synthesized the next generation functionalized superparamagnetic cobalt ferrite (CoFe2O4) nanoparticles (NPs), and have further developed a top-down phosphoproteomics strategy coupling phosphoprotein enrichment enabled by the functionalized CoFe2O4 NPs with online liquid chromatography (LC)/MS/MS for comprehensive characterization of phosphoproteins. We have demonstrated the highly specific enrichment of a minimal amount of spike-in β-casein from a complex tissue lysate as well as effective separation and quantification of its phosphorylated genetic variants. More importantly, this integrated top-down phosphoproteomics strategy allows for enrichment, identification, quantification, and comprehensive characterization of low abundance endogenous phosphoproteins from complex tissue extracts on a chromatographic time scale.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Schematic illustration of the top-down phosphoproteomics strategy integrating intact phosphoprotein enrichment using functionalized magnetic nanoparticles (NPs) with online LC/MS/MS. (a) Proteins were extracted from tissue (or cell), and subjected to enrichment by functionalized CoFe2O4 NPs. (b) Phosphoproteins bound on magnetic NPs were then pulled down by a magnet for subsequent elution. (c) The loading mixture (LM), flow through (FT), and elution (E) were further separated and analyzed by top-down LC/MS. Enriched phosphoproteins are then comprehensively characterized by online LC/MS/MS. (d) Details of the CoFe2O4 NPs functionalized with GAPT-Zn ligands that specifically bind to phosphate groups.
Fig. 2
Fig. 2. (a) Schematic illustration of the synthesis of functionalized CoFe2O4 NPs. The GAPT-Zn chelating groups possess strong binding ability and preference for phosphate dianions at neutral pH. (b) TEM image of as-prepared CoFe2O4–OA/OE NPs. Inset shows the size distribution (9.96 ± 1.03 nm) of the NPs. (c) PXRD pattern of as-synthesized CoFe2O4–OA/OE NPs. Blue dash lines indicate a typical diffraction pattern of a ferrite structure. (d) FTIR and (e) TGA analysis of as-synthesized CoFe2O4–OA/OE (black), functionalized CoFe2O4–NH3/PEG (red), and functionalized CoFe2O4–GAPT (blue) NPs.
Fig. 3
Fig. 3. SDS-PAGE analysis with (a) Sypro Ruby and (b) Pro-Q Diamond based detection of spike-in β-casein and other endogenous phosphoproteins specifically enriched from highly complex swine heart tissue extracts (loading mixture). Each loading mixture (LM) contains different concentration of 0.03 μg μL–1 (I), 0.05 μg μL–1 (II), 0.07 μg μL–1 (III), and 0.1 μg μL–1 (IV) of spiked-in β-casein. Equal amount (10 μg) of the loading mixture, flow-through (FT), and elution after enrichment (E) was loaded on the gel. M: marker; LM: loading mixture; FT: flow through; E: elution.
Fig. 4
Fig. 4. Top-down LC/MS analysis of multiple β-casein variants after phosphoprotein enrichment from a swine heart tissue extract with 0.05 μg μL–1 of spike-in β-casein. (a) Base peak chromatograms of LM (loading mixture; dark blue), FT (flow through; light blue), and E (elution; red). (i), (ii), and (iii), represent extracted ion chromatograms of β-casein variants. (b) Average mass spectra and deconvoluted spectra of LM (dark blue), FT (light blue), and E (red) samples from 41.3 to 41.7 min (highlighted in grey). The intensity in the region from 23 940 Da to 24 040 Da was magnified 3 times. NL: normalized level. (c) Cartoon illustration of the three β-casein variants B (i), A1 (ii), and A2 (iii), each carrying five phosphorylations.
Fig. 5
Fig. 5. LC/MS detection of well characterized cardiac phosphoproteins enabled by highly specific NP-based enrichment from a complex tissue extract. Representative endogenous phosphoproteins, (a) cardiac troponin I (cTnI) and (b) tropomyosin (Tm) were shown by comparing normalized deconvoluted average MS spectra of loading mixture (LM), flow through (FT), and elution from 37.5–37.8 min and 41.3–41.4 min, respectively. Mass difference of 28 Da corresponding to polymorphism V116A was observed for cTnI.
Fig. 6
Fig. 6. LC/MS/MS analysis of a representative previously uncharacterized phosphoprotein, hepatoma-derived growth factor, enabled by effective CoFe2O4 NP-based enrichment from a complex swine heart tissue extract. (a) MS spectra of loading mixture (LM, dark blue), flow through (FT, light blue), and elution (E, red) from 32.3 min to 32.7 min; (b) the corresponding deconvoluted spectra. (c) Fragment ion map of online MS/MS analysis with CID and ETD from triply phosphorylated precursor ion (29+). Grey “M” indicates methionine excision and red “S” indicates phosphorylation sites. Red numbers above the underlined red sequence reveal modifications with their additional mass. (d) Representative fragment ions from both online CID and ETD LC/MS/MS of the targeted protein.

Similar articles

Cited by

References

    1. Hunter T. Cell. 2000;100:113–127. - PubMed
    1. Humphrey S. J., Azimifar S. B., Mann M. Nat. Biotechnol. 2015;33:990–995. - PubMed
    1. Julien S. G., Dubé N., Hardy S., Tremblay M. L. Nat. Rev. Cancer. 2011;11:35–49. - PubMed
    1. Banks R. E., Dunn M. J., Hochstrasser D. F., Sanchez J. C., Blackstock W., Pappin D. J., Selby P. J. Lancet. 2000;356:1749–1756. - PubMed
    1. Gregorich Z. R., Ge Y. Proteomics. 2014;14:1195–1210. - PMC - PubMed

LinkOut - more resources